BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

935 related articles for article (PubMed ID: 29273668)

  • 1. Investigating fractional exhaled nitric oxide (FeNO) in chronic obstructive pulmonary disease (COPD) and asthma-COPD overlap (ACO): a scoping review protocol.
    Mostafavi-Pour-Manshadi SM; Naderi N; Barrecheguren M; Dehghan A; Bourbeau J
    BMJ Open; 2017 Dec; 7(12):e018954. PubMed ID: 29273668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating Fractional Exhaled Nitric Oxide in Chronic Obstructive Pulmonary Disease (COPD) and Asthma-COPD Overlap (ACO): A Scoping Review.
    Mostafavi-Pour-Manshadi SM; Naderi N; Barrecheguren M; Dehghan A; Bourbeau J
    COPD; 2018; 15(4):377-391. PubMed ID: 30067401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma-COPD overlap.
    Takayama Y; Ohnishi H; Ogasawara F; Oyama K; Kubota T; Yokoyama A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2525-2532. PubMed ID: 30174422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of fractional exhaled nitric oxide in differentiating the asthma-COPD overlap from COPD: a systematic review and meta-analysis.
    Zhang C; Zhang M; Wang Y; Su X; Lei T; Yu H; Liu J
    Expert Rev Respir Med; 2022 Jun; 16(6):679-687. PubMed ID: 34821171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Fractional Exhaled Nitric Oxide in Elderly Patients with Asthma-chronic Obstructive Pulmonary Disease Overlap and Other Airway Inflammatory Diseases.
    Shi F; Qiu C; Yu J; Yang Y; Li B; Feng M; Zhang T; Liu W
    Iran J Allergy Asthma Immunol; 2018 Jun; 17(3):232-239. PubMed ID: 29908540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of fractional exhaled nitric oxide in the differentiation of asthma-COPD overlap syndrome, asthma, and COPD.
    Chen FJ; Huang XY; Liu YL; Lin GP; Xie CM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2385-2390. PubMed ID: 27713629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The value of fractionated exhaled nitric oxide in the diagnosis of asthma-chronic obstructive pulmonary disease overlap syndrome].
    Deng DD; Zhou AY; Shuang QC; Chen P
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Feb; 40(2):98-101. PubMed ID: 28209039
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of airway inflammation in patients with COPD using fractional exhaled nitric oxide levels: a pilot study.
    Donohue JF; Herje N; Crater G; Rickard K
    Int J Chron Obstruct Pulmon Dis; 2014; 9():745-51. PubMed ID: 25053884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Value of Inflammatory Biomarkers in Differentiating Asthma-COPD Overlap from COPD.
    Li M; Yang T; He R; Li A; Dang W; Liu X; Chen M
    Int J Chron Obstruct Pulmon Dis; 2020; 15():3025-3037. PubMed ID: 33244228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease Severity.
    Feng JX; Lin Y; Lin J; He SS; Chen MF; Wu XM; Xu YZ
    J Korean Med Sci; 2017 Mar; 32(3):439-447. PubMed ID: 28145647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of a New Algorithm to Identify Asthma-COPD Overlap (ACO) Patients in a Cohort of Patients with Chronic Obstructive Airway Disease.
    Pérez de Llano L; Cosío BG; Miravitlles M; Plaza V;
    Arch Bronconeumol (Engl Ed); 2018 Apr; 54(4):198-204. PubMed ID: 29229474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of exhaled nitric oxide to inhaled corticosteroids in patients with stable COPD: A systematic review and meta-analysis.
    Lim CS; Rani FA; Tan LE
    Clin Respir J; 2018 Jan; 12(1):218-226. PubMed ID: 27328740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exhaled nitric oxide in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Lu Z; Huang W; Wang L; Xu N; Ding Q; Cao C
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2695-2705. PubMed ID: 30214187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albuterol inhalation increases FeNO level in steroid-naive asthmatics but not COPD patients with reversibility.
    Zhao H; Li R; Lv Y; Dong H; Yao L; Wu Y; Xiao G; Cai S
    Clin Respir J; 2017 May; 11(3):328-336. PubMed ID: 26077165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and NObreath.
    Harnan SE; Tappenden P; Essat M; Gomersall T; Minton J; Wong R; Pavord I; Everard M; Lawson R
    Health Technol Assess; 2015 Oct; 19(82):1-330. PubMed ID: 26484874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of fractional nitric oxide in exhaled breath (FeNO) in clinical practice of asthma].
    Nagase H
    Rinsho Byori; 2014 Dec; 62(12):1226-33. PubMed ID: 25823239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Magnesium and Fractional Exhaled Nitric Oxide in Relation to the Severity in Asthma-Chronic Obstructive Pulmonary Disease Overlap.
    Ye M; Li Q; Xiao L; Zheng Z
    Biol Trace Elem Res; 2021 May; 199(5):1771-1777. PubMed ID: 32948976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asthma-COPD Overlap Syndrome (ACOS): Single disease entity or not? Could exhaled nitric oxide be a useful biomarker for the differentiation of ACOS, asthma and COPD?
    Karampitsakos T; Gourgoulianis KI
    Med Hypotheses; 2016 Jun; 91():20-23. PubMed ID: 27142135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractional Exhaled Nitric Oxide Guided-Therapy in Chronic Obstructive Pulmonary Disease: A Stratified, Randomized, Controlled Trial.
    Su KC; Ko HK; Hsiao YH; Chou KT; Chen YW; Yu WK; Pan SW; Feng JY; Perng DW
    Arch Bronconeumol; 2022 Aug; 58(8):601-610. PubMed ID: 35312525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An official JRS statement: The principles of fractional exhaled nitric oxide (FeNO) measurement and interpretation of the results in clinical practice.
    Matsunaga K; Kuwahira I; Hanaoka M; Saito J; Tsuburai T; Fukunaga K; Matsumoto H; Sugiura H; Ichinose M;
    Respir Investig; 2021 Jan; 59(1):34-52. PubMed ID: 32773326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.